TGA Approval

LAMISIL terbinafine 125mg (as hydrochloride) tablet blister pack (43522)

ARTG ID

43522

ARTG Name

LAMISIL terbinafine 125mg (as hydrochloride) tablet blister pack

Sponsor

Novartis Pharmaceuticals Australia Pty Ltd

ARTG Date

September 24, 1993

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

Novartis Pharmaceuticals Australia Pty Ltd.

https://medical-cdn.nocode.com/drug_tga/d6def53408c630a73659973a5dc802b5.pdf

Ingredient Name

terbinafine hydrochloride

Empowering clinical research with data-driven insights and AI-powered tools.

LAMISIL terbinafine 125mg (as hydrochloride) tablet blister pack (43522) - TGA 批准文号 | MedPath